Question

Difficulty: HardSubstance-Related and Addictive Disorders

A 54-year-old man with a severe alcohol use disorder is brought to the emergency department by emergency medical services due to confusion and unsteadiness. He was found wandering in the street. His last alcoholic drink was approximately 24 hours ago. On presentation, he is diaphoretic, tachycardic (heart rate 118/min), and visibly tremulous. Neurologic examination reveals bilateral horizontal nystagmus, a wide-based ataxic gait, and profound global confusion. Point-of-care blood glucose testing shows 58 mg/dL (3.2 mmol/L). The patient is admitted to the hospital.

Arrange the following management steps in the most appropriate chronological sequence for this patient, from immediate acute stabilization to pre-discharge planning.

  1. 1Administer intravenous thiamine
  2. 2Administer intravenous dextrose
  3. 3Initiate symptom-triggered intravenous lorazepam
  4. 4Perform a comprehensive psychosocial evaluation
  5. 5Initiate oral naltrexone as maintenance pharmacotherapy

Answer

The correct chronological sequence is to first administer intravenous thiamine, followed by intravenous dextrose, then initiate symptom-triggered intravenous lorazepam, perform a comprehensive psychosocial evaluation, and finally initiate oral naltrexone as maintenance pharmacotherapy.
The management of severe alcohol use disorder requires a structured, chronological approach that prioritizes immediate, life-threatening conditions before addressing long-term recovery. This patient presents with the classic triad of Wernicke encephalopathy (confusion, ataxia, nystagmus) and concurrent hypoglycemia. Because thiamine is an essential cofactor for glucose metabolism, administering glucose without thiamine can precipitate severe, irreversible neurologic damage. Therefore, intravenous thiamine is the absolute first step. Immediately following thiamine, intravenous dextrose is given to correct the hypoglycemia. Once these acute metabolic derangements are addressed, the focus shifts to treating his acute alcohol withdrawal (manifested by tremor, tachycardia, and diaphoresis) using symptom-triggered benzodiazepines such as lorazepam to prevent seizures and delirium tremens. After the patient is medically cleared, sober, and free of acute withdrawal symptoms, a comprehensive psychosocial evaluation is performed to gauge his readiness for behavioral change. Finally, as part of discharge planning, maintenance pharmacotherapy such as naltrexone is initiated to reduce cravings and prevent long-term relapse.

Step-by-Step Solution

1
Identify the immediate metabolic threats: Wernicke encephalopathy and hypoglycemia.
Recognize that thiamine must precede glucose administration.
Glucose metabolism rapidly utilizes thiamine as a cofactor. Administering glucose without thiamine to a malnourished patient can severely deplete remaining stores, worsening Wernicke encephalopathy.
2
Address the life-threatening hypoglycemia.
Administer intravenous dextrose.
A blood glucose level of 58 mg/dL contributes to global confusion and must be corrected immediately after thiamine is provided.
3
Manage the acute alcohol withdrawal syndrome.
Initiate symptom-triggered intravenous lorazepam.
The patient is diaphoretic, tachycardic, and tremulous approximately 24 hours after his last drink, indicating acute withdrawal. Benzodiazepines are required to prevent progression to withdrawal seizures or delirium tremens.
4
Transition to post-acute care and recovery planning.
Perform a comprehensive psychosocial evaluation.
Medical stabilization must be fully achieved before a meaningful assessment of the patient's support system, psychiatric comorbidities, and readiness to change can be conducted.
5
Initiate relapse prevention therapy.
Prescribe oral naltrexone.
Once the patient is detoxified, oriented, and assessed, long-term pharmacotherapy is initiated prior to discharge to reduce cravings and decrease the risk of relapse.

Key Concept

Sequential management of severe alcohol use disorder requires immediate metabolic stabilization (thiamine before dextrose), followed by acute withdrawal management (benzodiazepines), and finally post-acute rehabilitation (psychosocial evaluation and maintenance pharmacotherapy).
Rate this question